|
Austria-Le-Le Azienda Directories
|
Azienda News:
- One shot to stop HIV: MITs bold vaccine breakthrough
Massachusetts Institute of Technology "One shot to stop HIV: MIT's bold vaccine breakthrough " ScienceDaily ScienceDaily, 20 June 2025 <www sciencedaily com releases 2025 06
- Supercharged vaccine could offer strong protection with just . . .
Researchers generated a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants to the vaccine This strategy could lead to vaccines that only need to be given once, for infectious diseases including HIV or SARS-CoV-2
- Always ‘one atom away’: The long, rocky journey to an HIV . . .
Note: Lenacapavir PrEP was Science’s 2024 Breakthrough of the Year For his contribution to its development, Sundquist was awarded the AAAS Mani L Bhaumik Breakthrough of the Year Award on 8 May, along with Moupali Das,vice president, clinical development, HIV prevention and pediatrics at Gilead; and Yvette Raphael, co-founder and executive director of Advocacy for Prevention of HIV and AIDS
- HIV: Supercharged vaccine could protect well with just one dose
A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated
- MITs one-shot vaccine could deliver robust protection from HIV
Interestingly, this breakthrough comes just as the US Food and Drug Administration (FDA) approved Lenacapavir, a twice-yearly injection that's described as a 'near-perfect shield against HIV
- FDA approves Gilead HIV prevention injection lenacapavir
The Food and Drug Administration on Wednesday approved Gilead' s twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the
- Twice-a-year shot to prevent HIV approved in U. S. | CBC News
The U S has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday While a vaccine to prevent HIV still is needed, some experts say the shot
|
|